2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Tarjoustasot
First North Denmark
Määrä
Osto
23 554
Myynti
Määrä
10 724
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 86 | - | - | ||
| 83 | - | - | ||
| 4 604 | - | - | ||
| 1 573 | - | - | ||
| 175 | - | - |
Ylin
1,465VWAP
Alin
1,42VaihtoMäärä
0 12 010
VWAP
Ylin
1,465Alin
1,42VaihtoMäärä
0 12 010
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·22 t sittenIt's taking a bit of a beating these days 😅·18 t sittenI still see the recent large increase as a quintessential example of pump and dump. And thus there was no substance in that increase at all, and in that light, I only find it natural that it falls back. But how far down it will go, I don't know. To me, it looks like they made a real and very exciting acquisition, which I think could well become a real asset for stenocare in the future. What will happen in the near future? Who knows? One can hope for positive news regarding the financial report, however, it is concerning that stenocare has not been very good at living up to what they promise.
- ·7.1.Good morning. TECHNICAL ANALYSIS d. 7/7/26 https://www.tradingview.com/x/pydoxdOg/ Daily timeframe It's three weeks since I wrote my last post about the big sell-off we saw in the stock, and how it was quickly bought up again, leaving a long daily-wick of about 20%. You can optionally go back to the post from d. 17/12/25 to get the context. After the strong sell-off, the price has clearly been bought up again, which shows that there is strong support at the bottom of the movement. Every time the market dips into the area, buyers step in — and this is often a sign that the worst panic is out of the system. https://www.tradingview.com/x/vaE6zwob/ Weekly timeframe On the weekly timeframe, we see a classic S/R-flip: a previous resistance level has been broken and now acts as support. When the market accepts prices above an old resistance level, it increases the probability that the movement will continue upwards — as long as the support holds. https://www.tradingview.com/x/RXkk7xDU/ Daily timeframe Anchored VWAP from the bottom – briefly explained: Anchored VWAP shows the average price investors have collectively paid since a specific point in time, weighted by volume. When it is anchored at the bottom of the chart, it thus shows the average price for all trades since the bottom. The fact that the price is now above Anchored VWAP and testing it from above means that most who have bought since the bottom are still in profit. This makes the VWAP line a natural support level, because buyers often defend it. If it holds — the sentiment is typically positive. Subsequently, we have another sell-off, but this time directly into a central support zone, where Anchored VWAP is also located. This tells us that a large part of the market's volume is below the current price — which gives a slightly bullish bias. https://www.tradingview.com/x/yZzp7S4m/ 4hr timeframe On the 4-hour chart, it is clearly seen how the market structure is bullish. We see higher highs and higher lows which is a healthy upward structure. At the same time, we have seen a break up through the area around 1.70. This is an important level because the market has reacted there several times before. When such a level is broken upwards and subsequently holds as support, it is often a confirmation that buyers are in control. https://www.tradingview.com/x/gN995kuW/ 4hr timeframe Overall, the picture points towards an overall bullish development, as long as the price holds above the central support areas — especially the SR-flip zone, Golden pocket (yellow lines) and the Anchored VWAP level. If we continue to get higher lows, and the price is accepted above 1.70.-, it further strengthens the case. If, on the other hand, we clearly break down below the support again, one must be aware of the risk that the movement was merely a false breakout, and that sellers can take back control. https://www.reuters.com/article/business/jazz-pharma-to-buy-gw-pharma-for-72-billion-adding-cannabis-based-drug-to-por-idUSKBN2A31RL/ In the cannabis and pharmaceutical sector, we have previously seen larger pharma companies acquire companies with strong pipeline or niche products. A clear example is Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals for approximately 7.2 billion dollars. This shows that major players assess that the market for cannabis-based medicines has long-term potential. This does not mean that Stenocare will necessarily be acquired — but it can contribute to a more positive sector sentiment around companies in the same field. As always; it's your money and your responsibility. These were just my thoughts on market structure. I have bought into this dip myself and expect at least that we will soon test zone 1.7.- again! - I am bullish on the stock here! I am happy to answer questions below. Have a good day·19 t sittenBig Pharma will NEVER ever look at or even consider a case like StenoCare, that is for sure. StenoCare is not biotech, and has no IP or any such market foothold that makes them unique in such a scene for Big Pharma. Never.
- ·6.1.Hope you've had a good start to the new year! I will do an in-depth analysis today or tomorrow. It will undoubtedly be an exciting coming year, and I see no reason to doubt the company. Conversely, I see a greater chance for higher prices!. More on that later! Have a good day :) Sebastian
- ·6.1.For about 1½ years now, it has been fluctuating around here with small ups and downs... Anything at all that suggests it will change, or should one just take the loss and buy something else.. As it looks now, I would have been better off if I had kept my Ørsted and not sold to buy this here.....sigh
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·22 t sittenIt's taking a bit of a beating these days 😅·18 t sittenI still see the recent large increase as a quintessential example of pump and dump. And thus there was no substance in that increase at all, and in that light, I only find it natural that it falls back. But how far down it will go, I don't know. To me, it looks like they made a real and very exciting acquisition, which I think could well become a real asset for stenocare in the future. What will happen in the near future? Who knows? One can hope for positive news regarding the financial report, however, it is concerning that stenocare has not been very good at living up to what they promise.
- ·7.1.Good morning. TECHNICAL ANALYSIS d. 7/7/26 https://www.tradingview.com/x/pydoxdOg/ Daily timeframe It's three weeks since I wrote my last post about the big sell-off we saw in the stock, and how it was quickly bought up again, leaving a long daily-wick of about 20%. You can optionally go back to the post from d. 17/12/25 to get the context. After the strong sell-off, the price has clearly been bought up again, which shows that there is strong support at the bottom of the movement. Every time the market dips into the area, buyers step in — and this is often a sign that the worst panic is out of the system. https://www.tradingview.com/x/vaE6zwob/ Weekly timeframe On the weekly timeframe, we see a classic S/R-flip: a previous resistance level has been broken and now acts as support. When the market accepts prices above an old resistance level, it increases the probability that the movement will continue upwards — as long as the support holds. https://www.tradingview.com/x/RXkk7xDU/ Daily timeframe Anchored VWAP from the bottom – briefly explained: Anchored VWAP shows the average price investors have collectively paid since a specific point in time, weighted by volume. When it is anchored at the bottom of the chart, it thus shows the average price for all trades since the bottom. The fact that the price is now above Anchored VWAP and testing it from above means that most who have bought since the bottom are still in profit. This makes the VWAP line a natural support level, because buyers often defend it. If it holds — the sentiment is typically positive. Subsequently, we have another sell-off, but this time directly into a central support zone, where Anchored VWAP is also located. This tells us that a large part of the market's volume is below the current price — which gives a slightly bullish bias. https://www.tradingview.com/x/yZzp7S4m/ 4hr timeframe On the 4-hour chart, it is clearly seen how the market structure is bullish. We see higher highs and higher lows which is a healthy upward structure. At the same time, we have seen a break up through the area around 1.70. This is an important level because the market has reacted there several times before. When such a level is broken upwards and subsequently holds as support, it is often a confirmation that buyers are in control. https://www.tradingview.com/x/gN995kuW/ 4hr timeframe Overall, the picture points towards an overall bullish development, as long as the price holds above the central support areas — especially the SR-flip zone, Golden pocket (yellow lines) and the Anchored VWAP level. If we continue to get higher lows, and the price is accepted above 1.70.-, it further strengthens the case. If, on the other hand, we clearly break down below the support again, one must be aware of the risk that the movement was merely a false breakout, and that sellers can take back control. https://www.reuters.com/article/business/jazz-pharma-to-buy-gw-pharma-for-72-billion-adding-cannabis-based-drug-to-por-idUSKBN2A31RL/ In the cannabis and pharmaceutical sector, we have previously seen larger pharma companies acquire companies with strong pipeline or niche products. A clear example is Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals for approximately 7.2 billion dollars. This shows that major players assess that the market for cannabis-based medicines has long-term potential. This does not mean that Stenocare will necessarily be acquired — but it can contribute to a more positive sector sentiment around companies in the same field. As always; it's your money and your responsibility. These were just my thoughts on market structure. I have bought into this dip myself and expect at least that we will soon test zone 1.7.- again! - I am bullish on the stock here! I am happy to answer questions below. Have a good day·19 t sittenBig Pharma will NEVER ever look at or even consider a case like StenoCare, that is for sure. StenoCare is not biotech, and has no IP or any such market foothold that makes them unique in such a scene for Big Pharma. Never.
- ·6.1.Hope you've had a good start to the new year! I will do an in-depth analysis today or tomorrow. It will undoubtedly be an exciting coming year, and I see no reason to doubt the company. Conversely, I see a greater chance for higher prices!. More on that later! Have a good day :) Sebastian
- ·6.1.For about 1½ years now, it has been fluctuating around here with small ups and downs... Anything at all that suggests it will change, or should one just take the loss and buy something else.. As it looks now, I would have been better off if I had kept my Ørsted and not sold to buy this here.....sigh
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
23 554
Myynti
Määrä
10 724
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 86 | - | - | ||
| 83 | - | - | ||
| 4 604 | - | - | ||
| 1 573 | - | - | ||
| 175 | - | - |
Ylin
1,465VWAP
Alin
1,42VaihtoMäärä
0 12 010
VWAP
Ylin
1,465Alin
1,42VaihtoMäärä
0 12 010
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·22 t sittenIt's taking a bit of a beating these days 😅·18 t sittenI still see the recent large increase as a quintessential example of pump and dump. And thus there was no substance in that increase at all, and in that light, I only find it natural that it falls back. But how far down it will go, I don't know. To me, it looks like they made a real and very exciting acquisition, which I think could well become a real asset for stenocare in the future. What will happen in the near future? Who knows? One can hope for positive news regarding the financial report, however, it is concerning that stenocare has not been very good at living up to what they promise.
- ·7.1.Good morning. TECHNICAL ANALYSIS d. 7/7/26 https://www.tradingview.com/x/pydoxdOg/ Daily timeframe It's three weeks since I wrote my last post about the big sell-off we saw in the stock, and how it was quickly bought up again, leaving a long daily-wick of about 20%. You can optionally go back to the post from d. 17/12/25 to get the context. After the strong sell-off, the price has clearly been bought up again, which shows that there is strong support at the bottom of the movement. Every time the market dips into the area, buyers step in — and this is often a sign that the worst panic is out of the system. https://www.tradingview.com/x/vaE6zwob/ Weekly timeframe On the weekly timeframe, we see a classic S/R-flip: a previous resistance level has been broken and now acts as support. When the market accepts prices above an old resistance level, it increases the probability that the movement will continue upwards — as long as the support holds. https://www.tradingview.com/x/RXkk7xDU/ Daily timeframe Anchored VWAP from the bottom – briefly explained: Anchored VWAP shows the average price investors have collectively paid since a specific point in time, weighted by volume. When it is anchored at the bottom of the chart, it thus shows the average price for all trades since the bottom. The fact that the price is now above Anchored VWAP and testing it from above means that most who have bought since the bottom are still in profit. This makes the VWAP line a natural support level, because buyers often defend it. If it holds — the sentiment is typically positive. Subsequently, we have another sell-off, but this time directly into a central support zone, where Anchored VWAP is also located. This tells us that a large part of the market's volume is below the current price — which gives a slightly bullish bias. https://www.tradingview.com/x/yZzp7S4m/ 4hr timeframe On the 4-hour chart, it is clearly seen how the market structure is bullish. We see higher highs and higher lows which is a healthy upward structure. At the same time, we have seen a break up through the area around 1.70. This is an important level because the market has reacted there several times before. When such a level is broken upwards and subsequently holds as support, it is often a confirmation that buyers are in control. https://www.tradingview.com/x/gN995kuW/ 4hr timeframe Overall, the picture points towards an overall bullish development, as long as the price holds above the central support areas — especially the SR-flip zone, Golden pocket (yellow lines) and the Anchored VWAP level. If we continue to get higher lows, and the price is accepted above 1.70.-, it further strengthens the case. If, on the other hand, we clearly break down below the support again, one must be aware of the risk that the movement was merely a false breakout, and that sellers can take back control. https://www.reuters.com/article/business/jazz-pharma-to-buy-gw-pharma-for-72-billion-adding-cannabis-based-drug-to-por-idUSKBN2A31RL/ In the cannabis and pharmaceutical sector, we have previously seen larger pharma companies acquire companies with strong pipeline or niche products. A clear example is Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals for approximately 7.2 billion dollars. This shows that major players assess that the market for cannabis-based medicines has long-term potential. This does not mean that Stenocare will necessarily be acquired — but it can contribute to a more positive sector sentiment around companies in the same field. As always; it's your money and your responsibility. These were just my thoughts on market structure. I have bought into this dip myself and expect at least that we will soon test zone 1.7.- again! - I am bullish on the stock here! I am happy to answer questions below. Have a good day·19 t sittenBig Pharma will NEVER ever look at or even consider a case like StenoCare, that is for sure. StenoCare is not biotech, and has no IP or any such market foothold that makes them unique in such a scene for Big Pharma. Never.
- ·6.1.Hope you've had a good start to the new year! I will do an in-depth analysis today or tomorrow. It will undoubtedly be an exciting coming year, and I see no reason to doubt the company. Conversely, I see a greater chance for higher prices!. More on that later! Have a good day :) Sebastian
- ·6.1.For about 1½ years now, it has been fluctuating around here with small ups and downs... Anything at all that suggests it will change, or should one just take the loss and buy something else.. As it looks now, I would have been better off if I had kept my Ørsted and not sold to buy this here.....sigh
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
23 554
Myynti
Määrä
10 724
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 86 | - | - | ||
| 83 | - | - | ||
| 4 604 | - | - | ||
| 1 573 | - | - | ||
| 175 | - | - |
Ylin
1,465VWAP
Alin
1,42VaihtoMäärä
0 12 010
VWAP
Ylin
1,465Alin
1,42VaihtoMäärä
0 12 010
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 16 910 | 16 910 | 0 | 0 |






